{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:27:34Z","timestamp":1792013254602,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ygyno.2020.04.685","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T13:22:47Z","timestamp":1587993767000},"page":"112-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests \u2013 A European prospective single center study"],"prefix":"10.1016","volume":"158","author":[{"given":"Olaf","family":"Reich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Regauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kashofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.04.685_bb0005","series-title":"World Health Organization Classification of Tumours of the Female Reproductive Organs","article-title":"Tumours of the cervix: squamous cell tumours and precursors","author":"Stoler","year":"2014"},{"key":"10.1016\/j.ygyno.2020.04.685_bb0010","unstructured":"International Agency for the Research on Cancer; http:\/\/monographs.iarc.fr\/ENG\/Monographs\/vol90\/ accessed on 11 July 2015."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0020","article-title":"HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri","author":"Forslund","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.04.685_bb0025","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1002\/ijc.30032","article-title":"Evaluating HPV-negative CIN2+ in the ATHENA trial","volume":"138","author":"Petry","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.04.685_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1067\/mob.2003.439","article-title":"No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patients","volume":"189","author":"B\u00f6hmer","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/path.4405","article-title":"Retrospective International Survey and HPV Time Trends Study Group. Pathogenic role of the eight probably\/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer","volume":"234","author":"Halec","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0040","first-page":"1299","article-title":"RIS HPV TTHPV VVAPO study groups","volume":"37","author":"Guimera","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0045","article-title":"HPV 6-associated HSIL\/squamous carcinoma in the anogenital tract","author":"Liu","year":"2018","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/LGT.0000000000000486","article-title":"Low-risk human papillomavirus types in cervical intraepithelial neoplasia 2-3 and in invasive cervical cancer patients","volume":"23","author":"Siegler","year":"2019","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/PGP.0000000000000311","article-title":"Thin HSIL of the cervix: detecting a variant of high-grade squamous intraepithelial lesions with a p16INK4a antibody","volume":"36","author":"Reich","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/his.13869","article-title":"Thin variant of high-grade squamous intraepithelial lesion - relationship with high-risk and possibly carcinogenic human papilloma virus subtypes and somatic cancer gene mutations","volume":"75","author":"Regauer","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2020.04.685_bb0065","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/ijc.29651","article-title":"Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: results from a European multinational epidemiological study","volume":"137","author":"Holl","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.04.685_bb0070","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ygyno.2012.11.017","article-title":"Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review","volume":"128","author":"Tornesello","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0075","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/cncr.28288","article-title":"Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix","volume":"119","author":"Wright","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2020.04.685_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cjp2.27","article-title":"Somatic mutation in PIK3CA is a late event in cervical carcinogenesis","volume":"1","author":"Verlaat","year":"2015","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.ygyno.2020.04.685_bb0085","unstructured":"National Center for Biotechnology Information. ClinVar; variation ID 181805, https:\/\/preview.ncbi.nlm.nih.gov\/clinvar\/variation\/181805 (accessed June 25, 2019)."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820309859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820309859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:51:20Z","timestamp":1758772280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820309859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0090825820309859"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.04.685","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests \u2013 A European prospective single center study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.04.685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}